LiquADD is a new formulation of Dextroamphetamine for ADD/ADHD, which will come in a liquid. It was just announced that the FDA has approved this medicine and it will be released in the US in the second quarter of 2008.
What is LiquADD?
LiquADD is a liquid preparation of dextroamphetamine sulfate. This is a shorter acting stimulant medicine for ADHD. The advantage of this preparation is that it can be swallowed by children who have trouble swallowing pills.
Prior to LiquADD, the only liquid ADHD medication was Methylin – though it is a preparation of Methylphenidate, and this is of a different stimulant – i.e. Dextroamphetamine.
LiquADD is chemically similar to Adderall, though there are minor differences.
As LiquADD is a short acting stimulant, there is a chance of abuse of the medication, and caution will need to be exercised when prescribing it to teens at risk of drug abuse.
This is a welcomed addition to the medications for ADD and ADHD, as it will help for kids who cannot swallow pills.
As a reminder – there are medications which can be ‘sprinkled’ (i.e. capsules which can be opened and sprinkled to facilitate swallowing), and they include:
- Ritalin LA
- Metadate CD
- Biphentin (in Canada)
- Focalin XR
- Dexedrine Spansules
- Adderall XR
There is also the Daytrana patch available in the US – which is a patch of Methylphenidate – so that the medication is absorbed through the skin, rather than by pill.
p.s. The article referenced above indicates that ADHD Medication is a $3.5 Billion a year market. If you are concerned, confused or want to get the straight facts about these medicines, please visit Medication Mastery for a free special report.
[tags] LiquADD, Adderall, Vyvanse, Daytrana, ADHD, ADD, Medication, Parenting [/tags]